---
title: | Elixir (2)
description: (2)
---

[![Elixir_Logo_Tag](https://visiblydifferent.envisionrx.com/hubfs/Elixir_Logo_Tag.png "Elixir_Logo_Tag")](http://www.elixirsolutions.com)

#### Elixir

### Recent Posts

#### [Looking Ahead to 2023: Medicare Readiness](https://blog.elixirsolutions.com/looking-ahead-to-2023-medicare-readiness)

** [Industry Updates](https://blog.elixirsolutions.com/tag/industry-updates)

The 2022 audit cycle is coming to a close. CMS issued its last engagement letters for 2022 program audits at the end of...

[Read More](https://blog.elixirsolutions.com/looking-ahead-to-2023-medicare-readiness)

[![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Blog%20Feature%20Images/child-looking-through-eyeglass.jpg) ](https://blog.elixirsolutions.com/looking-ahead-to-2023-medicare-readiness)

#### [New Guidelines for Diabetes First Line Therapy Could Lead to Increases in Drug Spend](https://blog.elixirsolutions.com/new-guidelines-for-diabetes-first-line-therapy)

** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights), ** [Industry Updates](https://blog.elixirsolutions.com/tag/industry-updates)

Diabetes is an epidemic that drives a significant amount of medical cost. Eleven percent of the United States’...

[Read More](https://blog.elixirsolutions.com/new-guidelines-for-diabetes-first-line-therapy)

[![](https://blog.elixirsolutions.com/hubfs/Diabetes%20iStock-1185738340.jpg) ](https://blog.elixirsolutions.com/new-guidelines-for-diabetes-first-line-therapy)

#### [Elixir’s 2023 Formularies Drive Optimal Value with Under 1% Member Disruption](https://blog.elixirsolutions.com/elixirs-2023-formularies)

** [Industry Updates](https://blog.elixirsolutions.com/tag/industry-updates), ** [Trends & Insights](https://blog.elixirsolutions.com/tag/trends-insights)

At Elixir, whole member health is at the heart of our formulary strategy and drug management practices. As we prepare...

[Read More](https://blog.elixirsolutions.com/elixirs-2023-formularies)

[![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Diabetes-900x600-1.jpg) ](https://blog.elixirsolutions.com/elixirs-2023-formularies)

#### [Taking the Limits Out of Limited Distribution Drugs for Specialty Medication Access](https://blog.elixirsolutions.com/unraveling-a-common-practice-for-a-complex-situation)

** [Trends & Insights](https://blog.elixirsolutions.com/tag/trends-insights)

Specialty medications are not only used to treat complex conditions, they are themselves complex in nature. Some have...

[Read More](https://blog.elixirsolutions.com/unraveling-a-common-practice-for-a-complex-situation)

[![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Blog%20Feature%20Images/girl-chasing-kite.jpg) ](https://blog.elixirsolutions.com/unraveling-a-common-practice-for-a-complex-situation)

#### [Inflation Reduction Act of 2022: The Basics](https://blog.elixirsolutions.com/inflation-reduction-act-of-2022-the-basics)

** [Industry Updates](https://blog.elixirsolutions.com/tag/industry-updates)

On August 16th, 2022, President Biden signed into law H.R. 5376, a budget reconciliation measure known as the Inflation...

[Read More](https://blog.elixirsolutions.com/inflation-reduction-act-of-2022-the-basics)

[![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Blog%20Feature%20Images/Retired-man-sorts-medication.jpg) ](https://blog.elixirsolutions.com/inflation-reduction-act-of-2022-the-basics)

#### [What to Know for the 2022-2023 Flu Season](https://blog.elixirsolutions.com/what-to-know-for-the-2022-2023-flu-season)

** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights), ** [Industry Updates](https://blog.elixirsolutions.com/tag/industry-updates)

According to the Centers for Disease Control and Prevention (CDC), there were as many as 14,000 flu-related deaths and...

[Read More](https://blog.elixirsolutions.com/what-to-know-for-the-2022-2023-flu-season)

[![](https://blog.elixirsolutions.com/hubfs/Woman%20Young%20Sick%20Flu%20Couch%20Fever%20Blanket%20iStock-1175000095.jpg) ](https://blog.elixirsolutions.com/what-to-know-for-the-2022-2023-flu-season)

#### [Is it Worth the Download: Digital Therapeutics' Place in Healthcare](https://blog.elixirsolutions.com/digital-therapeutics-pop)

** [Perspective on the Rx Pipeline](https://blog.elixirsolutions.com/tag/perspective-on-the-rx-pipeline)

Digital therapeutics (DTx) uses software programs to prevent, manage or treat diseases. They may be used with or...

[Read More](https://blog.elixirsolutions.com/digital-therapeutics-pop)

[![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/DTx-8.png) ](https://blog.elixirsolutions.com/digital-therapeutics-pop)

#### [Biosimilars Versus Interchangeability: What You Need to Know](https://blog.elixirsolutions.com/biosimilars-versus-interchangeability)

** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights)

Specialty medications continue to be a large source of drug spend, in particular biologic drugs. Biosimilars pose an...

[Read More](https://blog.elixirsolutions.com/biosimilars-versus-interchangeability)

[![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Biosimilars-Part-2-Blog-Photo.png) ](https://blog.elixirsolutions.com/biosimilars-versus-interchangeability)

#### [Demonstrating the Value of Specialty Medications that Treat Cystic Fibrosis](https://blog.elixirsolutions.com/cystic-fibrosis-kpi)

** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights)

Cystic fibrosis (CF) is a rare genetic disorder that affects one in 3,900 live births. There are approximately 30,000...

[Read More](https://blog.elixirsolutions.com/cystic-fibrosis-kpi)

[![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/CF7.png) ](https://blog.elixirsolutions.com/cystic-fibrosis-kpi)

#### [Insights for Remaining Audit Ready: CMS Releases 2021 Audit Enforcement Report](https://blog.elixirsolutions.com/cms-2021-audit-enforcement-report)

** [Industry Updates](https://blog.elixirsolutions.com/tag/industry-updates)

On June 7, 2022, the Centers for Medicare and Medicaid Services (CMS) released the *2021 Part C and Part D Program Audit...*

[Read More](https://blog.elixirsolutions.com/cms-2021-audit-enforcement-report)

[![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Audit-2.jpg) ](https://blog.elixirsolutions.com/cms-2021-audit-enforcement-report)

[** ](https://blog.elixirsolutions.com/author/elixir/page/1) 2 [3 ](https://blog.elixirsolutions.com/author/elixir/page/3) [** ](https://blog.elixirsolutions.com/author/elixir/page/3)

### Post By Topic

- [Clinical Trends & Insights (17)](https://blog.elixirsolutions.com/tag/clinical-trends-insights)
- [Getting to know Elixir (7)](https://blog.elixirsolutions.com/tag/getting-to-know-elixir)
- [Industry Updates (20)](https://blog.elixirsolutions.com/tag/industry-updates)
- [Perspective on the Rx Pipeline (13)](https://blog.elixirsolutions.com/tag/perspective-on-the-rx-pipeline)
- [Solutions & Best Practices (22)](https://blog.elixirsolutions.com/tag/solutions-best-practices)
- [Trends & Insights (3)](https://blog.elixirsolutions.com/tag/trends-insights)

[See all](https://blog.elixirsolutions.com/author/elixir/page/2#)

### Receive Insights in your Inbox

[elixirsolutions.com](https://www.elixirsolutions.com/)

[![Share on linkedin](https://blog.elixirsolutions.com/hs-fs/hubfs/Root/Social%20Icons/linkedin-color.png?width=24&name=linkedin-color.png) ](https://www.linkedin.com/company/elixir-craftedrxsolutions/) [![Share on twitter](https://blog.elixirsolutions.com/hs-fs/hubfs/Root/Social%20Icons/twitter-color.png?width=24&name=twitter-color.png) ](https://twitter.com/ElixirPBM)

## [TERMS OF USE](https://www.elixirsolutions.com/home/terms-of-use)          [PRIVACY POLICY ](https://www.elixirsolutions.com/home/privacy-policy)         [PRIVACY NOTICE](https://www.elixirsolutions.com/home/privacy-notice)         [ NON-DISCRIMINATION POLICY](https://www.elixirsolutions.com/home/non-discrimination-policy)

## © 2026 Elixir All rights reserved 